Experimental evidence for the role of atherosclerosis in calcific aortic valve disease

Malayannan Subramaniam, Thomas C. Spelsberg, Nalini Marie Rajamannan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Calcific aortic stenosis is the most common indication for surgical valve replacement in the United States (www.sts.com). Currently, in 2012 surgical valve replacement is the number one indication for the treatment of this disease process (Bonow et al. 1998). For years, this disease has been described as a passive phenomena during which serum calcium attaches to the valve surface and binds to the leaflet to form nodules. Over decades, as aortic stenosis progressed, it will cause progressive left ventricular hypertrophy, left ventricular diastolic and systolic dysfunction, congestive heart failure, angina, arrhythmias, and syncope. Recent studies demonstrate an association between atherosclerotic risk factors and aortic valve disease. Although a unifying hypothesis for the role of atherosclerotic risk factors towards the mechanism of vascular and aortic valve disease is emerging, progress in studying the cell biology of this disease has been defining turning point in understanding the overall mechanisms.

Original languageEnglish (US)
Title of host publicationCardiac Valvular Medicine
PublisherSpringer-Verlag London Ltd
Pages23-33
Number of pages11
ISBN (Print)9781447141327, 9781447141310
DOIs
StatePublished - Jan 1 2013

Fingerprint

Aortic Diseases
Aortic Valve
Atherosclerosis
Surgical Instruments
Aortic Valve Stenosis
Syncope
Left Ventricular Hypertrophy
Blood Vessels
Cell Biology
Cardiac Arrhythmias
Heart Failure
Calcium
Serum
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Subramaniam, M., Spelsberg, T. C., & Rajamannan, N. M. (2013). Experimental evidence for the role of atherosclerosis in calcific aortic valve disease. In Cardiac Valvular Medicine (pp. 23-33). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-4132-7_4

Experimental evidence for the role of atherosclerosis in calcific aortic valve disease. / Subramaniam, Malayannan; Spelsberg, Thomas C.; Rajamannan, Nalini Marie.

Cardiac Valvular Medicine. Springer-Verlag London Ltd, 2013. p. 23-33.

Research output: Chapter in Book/Report/Conference proceedingChapter

Subramaniam, M, Spelsberg, TC & Rajamannan, NM 2013, Experimental evidence for the role of atherosclerosis in calcific aortic valve disease. in Cardiac Valvular Medicine. Springer-Verlag London Ltd, pp. 23-33. https://doi.org/10.1007/978-1-4471-4132-7_4
Subramaniam M, Spelsberg TC, Rajamannan NM. Experimental evidence for the role of atherosclerosis in calcific aortic valve disease. In Cardiac Valvular Medicine. Springer-Verlag London Ltd. 2013. p. 23-33 https://doi.org/10.1007/978-1-4471-4132-7_4
Subramaniam, Malayannan ; Spelsberg, Thomas C. ; Rajamannan, Nalini Marie. / Experimental evidence for the role of atherosclerosis in calcific aortic valve disease. Cardiac Valvular Medicine. Springer-Verlag London Ltd, 2013. pp. 23-33
@inbook{5f0243730d124b14b9709bfe47a79b6b,
title = "Experimental evidence for the role of atherosclerosis in calcific aortic valve disease",
abstract = "Calcific aortic stenosis is the most common indication for surgical valve replacement in the United States (www.sts.com). Currently, in 2012 surgical valve replacement is the number one indication for the treatment of this disease process (Bonow et al. 1998). For years, this disease has been described as a passive phenomena during which serum calcium attaches to the valve surface and binds to the leaflet to form nodules. Over decades, as aortic stenosis progressed, it will cause progressive left ventricular hypertrophy, left ventricular diastolic and systolic dysfunction, congestive heart failure, angina, arrhythmias, and syncope. Recent studies demonstrate an association between atherosclerotic risk factors and aortic valve disease. Although a unifying hypothesis for the role of atherosclerotic risk factors towards the mechanism of vascular and aortic valve disease is emerging, progress in studying the cell biology of this disease has been defining turning point in understanding the overall mechanisms.",
author = "Malayannan Subramaniam and Spelsberg, {Thomas C.} and Rajamannan, {Nalini Marie}",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-1-4471-4132-7_4",
language = "English (US)",
isbn = "9781447141327",
pages = "23--33",
booktitle = "Cardiac Valvular Medicine",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Experimental evidence for the role of atherosclerosis in calcific aortic valve disease

AU - Subramaniam, Malayannan

AU - Spelsberg, Thomas C.

AU - Rajamannan, Nalini Marie

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Calcific aortic stenosis is the most common indication for surgical valve replacement in the United States (www.sts.com). Currently, in 2012 surgical valve replacement is the number one indication for the treatment of this disease process (Bonow et al. 1998). For years, this disease has been described as a passive phenomena during which serum calcium attaches to the valve surface and binds to the leaflet to form nodules. Over decades, as aortic stenosis progressed, it will cause progressive left ventricular hypertrophy, left ventricular diastolic and systolic dysfunction, congestive heart failure, angina, arrhythmias, and syncope. Recent studies demonstrate an association between atherosclerotic risk factors and aortic valve disease. Although a unifying hypothesis for the role of atherosclerotic risk factors towards the mechanism of vascular and aortic valve disease is emerging, progress in studying the cell biology of this disease has been defining turning point in understanding the overall mechanisms.

AB - Calcific aortic stenosis is the most common indication for surgical valve replacement in the United States (www.sts.com). Currently, in 2012 surgical valve replacement is the number one indication for the treatment of this disease process (Bonow et al. 1998). For years, this disease has been described as a passive phenomena during which serum calcium attaches to the valve surface and binds to the leaflet to form nodules. Over decades, as aortic stenosis progressed, it will cause progressive left ventricular hypertrophy, left ventricular diastolic and systolic dysfunction, congestive heart failure, angina, arrhythmias, and syncope. Recent studies demonstrate an association between atherosclerotic risk factors and aortic valve disease. Although a unifying hypothesis for the role of atherosclerotic risk factors towards the mechanism of vascular and aortic valve disease is emerging, progress in studying the cell biology of this disease has been defining turning point in understanding the overall mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=84955402448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955402448&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-4132-7_4

DO - 10.1007/978-1-4471-4132-7_4

M3 - Chapter

AN - SCOPUS:84955402448

SN - 9781447141327

SN - 9781447141310

SP - 23

EP - 33

BT - Cardiac Valvular Medicine

PB - Springer-Verlag London Ltd

ER -